妙佑医疗国际的方法

协作

妙佑医疗国际与美国各地的医疗中心合作收集 COVID-19 康复患者的血浆。妙佑医疗国际负责协调这项政府资助的项目。

团队方式

来自多个不同领域的妙佑医疗医生协同合作,研究 COVID-19 的可行治疗方案。团队成员的专科领域包括:

  • 传染病。
  • 检验医学与病理学。
  • 血液采集与检测(输血医学)。
  • 药剂学。
  • 病毒研究(病毒学)。
  • 心血管疾病。
  • 初级保健。
  • 护理科。
  • 药剂科。
  • 输液治疗中心。

研究

妙佑医疗国际的研究人员正在研究导致 COVID-19 的病毒及其对免疫系统的影响。他们持续研究针对 COVID-19 的治疗药物和方法,并不断改进诊断与抗体检测技术。研究人员积极参与 COVID-19 和其他传染病的临床试验。

Dec. 30, 2025
  1. Investigational COVID-19 convalescent plasma. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma. Accessed March 24, 2025.
  2. Hoffman R, et al. Principles of plasma and plasma derivatives. In: Hematology. 8th edition. Elsevier. 2023. https://www.clinicalkey.com. Accessed March 24, 2025.
  3. Marano G, et al. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016; doi:10.2450/2015.0131-15.
  4. Emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed March 24, 2025.
  5. AskMayoExpert. COVID-19: Outpatient management. Convalescent Plasma. Mayo Clinic; 2025.
  6. Rajendran K, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Journal of Medical Virology. 2020; doi:10.1002/jmv.25961.
  7. Senefeld JW, et al. COVID-19 Convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. Journal of the American Medical Association: Network Open. 2023; doi:10.1001/jamanetworkopen.2022.50647.
  8. COVID-19 treatments and medications. Centers for Disease Control and Prevention. https://www.cdc.gov/covid/treatment/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html#cdc_treatment_overview-covid-19-treatment-options. Accessed March 24, 2025.
  9. Kim AY et al. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. https://www.uptodate.com/contents/search. Accessed March 24, 2025.
  10. Infectious disease, HLA and ABO donor qualification testing. American Red Cross. https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html. Accessed March 24, 2025.
  11. Medical review (expert opinion). Mayo Clinic. March 24, 2025.
  12. Whole Blood and blood components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived) and Apheresis Convalescent Plasma, High Titer, Anti-SARS-CoV-2). https://www.fda.gov/vaccines-blood-biologics/whole-blood-and-blood-components-convalescent-plasma-high-titer-anti-sars-cov-2-whole-blood-derived. Accessed April 4, 2025.
  13. Dragotakes Q, et al. Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proceedings of the National Academy of Sciences of the United States of America. 2024; doi:10.1073/pnas.2414957121.